Skip to main content

Table 1 The distribution and incidence of PS in this study

From: Risk factors and prognosis of malignant peritoneal mesothelioma with paraneoplastic syndrome

Paraneoplastic syndrome

n (%)a

Hematologic system

 Thrombocytosis

49 (33.6)

 Malignant tumor-associated thrombosis

2 (1.4)

 Anemia

2 (1.4)

Endocrine system

 Hypoglycemia

1 (0.7)

Urinary system

 Nephrotic syndrome

1 (0.7)

Other

 Neoplastic fever

14 (9.6)

 Unexplained pain

7 (4.8)

  1. PS paraneoplastic syndrome
  2. aOne patient may have multiple PS